Shire, Shionogi's ADHD drug for adults clears late-stage trial in Japan

TOKYO (Reuters) - Shire Plc and Shionogi& Co Ltd said a drug to treat ADHD in adults had met its main goal in a late-stage trial in Japan, bringing it one step closer to approval in the world's third-biggest market for ADHD treatments.

Source: Reuters: Health - September 20, 2017 Category: Consumer Health News Tags: healthNews Source Type: news